CCO Expert Recap

Acute Leukemias/Myelodysplastic Syndromes

Source: CCO Independent Conference Coverage of the American Society of Hematology 2008 Annual Meeting*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Acute Leukemias/Myelodysplastic Syndromes

Program Director: Roy A. Beveridge, MD

Faculty:

Hagop M. Kantarjian, MD

CREDIT INFORMATION

Release Date: 02/26/09

Expiration Date: 02/25/10

Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Registered Nurses: 1.1 Nursing contact hours

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss new data on the treatment of acute promyelocytic leukemia
Summarize the results of recent clinical trials investigating the addition of new agents to standard chemotherapy regimens for the treatment of acute myeloid leukemia
Recount recent findings on new therapeutic strategies for the treatment of myelodysplastic syndromes
Evaluate new data from clinical trials investigating low-intensity therapies for the treatment of elderly patients with myelodysplastic syndromes

CCO Expert Recaps combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.